| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advanced-Stage Follicular Lymphoma in the Rituximab Era
|
Pettengell, Ruth
|
|
2009
|
|
13 |
p. 1727-1737
|
artikel
|
| 2 |
Afatinib: First Global Approval
|
Dungo, Rosselle T.
|
|
2013
|
|
13 |
p. 1503-1515
|
artikel
|
| 3 |
Airmax™
|
Donohue, James F.
|
|
2002
|
|
13 |
p. 1896-1897
|
artikel
|
| 4 |
Airmax™
|
Frew, Anthony J.
|
|
2002
|
|
13 |
p. 1896
|
artikel
|
| 5 |
Airmax™
|
Chrystyn, Henry
|
|
2002
|
|
13 |
p. 1896
|
artikel
|
| 6 |
Airmax™
|
Keating, Gillian M.
|
|
2002
|
|
13 |
p. 1887-1895
|
artikel
|
| 7 |
Alitretinoin: A Review in Severe Chronic Hand Eczema
|
Blair, Hannah A.
|
|
2016
|
|
13 |
p. 1271-1279
|
artikel
|
| 8 |
Ampicillin/Sulbactam
|
Rafailidis, Petros I.
|
|
|
|
13 |
p. 1829-1849
|
artikel
|
| 9 |
Antithrombotic Therapy After Percutaneous Coronary Intervention in Atrial Fibrillation: The Triple Trouble
|
Leggio, Massimo
|
|
2018
|
|
13 |
p. 1309-1319
|
artikel
|
| 10 |
Anti-TNF Agents and New Biological Agents (Vedolizumab and Ustekinumab) in the Prevention and Treatment of Postoperative Recurrence After Surgery in Crohn’s Disease
|
Gisbert, Javier P.
|
|
|
|
13 |
p. 1179-1205
|
artikel
|
| 11 |
An Update on the Clinical Use of CDK4/6 Inhibitors in Breast Cancer
|
Robert, Marie
|
|
2018
|
|
13 |
p. 1353-1362
|
artikel
|
| 12 |
A Practical Approach to the Management of Radiation-Induced Hemorrhagic Cystitis
|
Liem, Xavier
|
|
2015
|
|
13 |
p. 1471-1482
|
artikel
|
| 13 |
Aprepitant
|
Curran, Monique P.
|
|
2009
|
|
13 |
p. 1853-1878
|
artikel
|
| 14 |
A Role for SGLT-2 Inhibitors in Treating Non-diabetic Chronic Kidney Disease
|
Del Vecchio, Lucia
|
|
|
|
13 |
p. 1491-1511
|
artikel
|
| 15 |
Belinostat: First Global Approval
|
Poole, Raewyn M.
|
|
2014
|
|
13 |
p. 1543-1554
|
artikel
|
| 16 |
Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in Spasticity
|
Santamato, Andrea
|
|
2017
|
|
13 |
p. 1413-1422
|
artikel
|
| 17 |
Cancer Pain Treatment Strategies in Patients with Cancer
|
Mercadante, Sebastiano
|
|
|
|
13 |
p. 1357-1366
|
artikel
|
| 18 |
Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain
|
Stella, Barbara
|
|
|
|
13 |
p. 1513-1557
|
artikel
|
| 19 |
Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections
|
Syed, Yahiya Y.
|
|
|
|
13 |
p. 1559-1571
|
artikel
|
| 20 |
Ceftobiprole Medocaril: A Review of Its Use in Patients with Hospital- or Community-Acquired Pneumonia
|
Syed, Yahiya Y.
|
|
2014
|
|
13 |
p. 1523-1542
|
artikel
|
| 21 |
Ceftobiprole Medocaril: A Review of Its Use in Patients with Hospital- or Community-Acquired Pneumonia
|
Syed, Yahiya Y.
|
|
|
|
13 |
p. 1523-1542
|
artikel
|
| 22 |
Chronic Renal Insufficiency in Heart Transplant Recipients: Risk Factors and Management Options
|
González-Vílchez, Francisco
|
|
2014
|
|
13 |
p. 1481-1494
|
artikel
|
| 23 |
Contezolid: First Approval
|
Hoy, Sheridan M.
|
|
|
|
13 |
p. 1587-1591
|
artikel
|
| 24 |
Correction: Tapinarof Cream 1%: First Approval
|
Keam, Susan J.
|
|
|
|
13 |
p. 1433
|
artikel
|
| 25 |
Correction to: Antithrombotic Therapy for Symptomatic Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis
|
Willems, Loes H.
|
|
|
|
13 |
p. 1435
|
artikel
|
| 26 |
Correction to: Camrelizumab: First Global Approval
|
Markham, Anthony
|
|
2019
|
|
13 |
p. 1497
|
artikel
|
| 27 |
Correction to: Concizumab: First Approval
|
Keam, Susan J.
|
|
|
|
13 |
p. 1253-1254
|
artikel
|
| 28 |
Correction to: Damoctocog Alfa Pegol: A Review in Haemophilia A
|
Paik, Julia
|
|
2019
|
|
13 |
p. 1495
|
artikel
|
| 29 |
Correction to: Fuzuloparib: First Approval
|
Lee, Arnold
|
|
|
|
13 |
p. 1597
|
artikel
|
| 30 |
Correction to: Galcanezumab: A Review in the Prevention of Migraine and Treatment of Episodic Cluster Headache
|
Scott, Lesley J.
|
|
|
|
13 |
p. 1379
|
artikel
|
| 31 |
Correction to: Management of Hypertension in Chronic Kidney Disease
|
Pugh, Dan
|
|
|
|
13 |
p. 1381
|
artikel
|
| 32 |
Correction to: Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections
|
Dhillon, Sohita
|
|
2018
|
|
13 |
p. 1383
|
artikel
|
| 33 |
Correction to: Suprachoroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema
|
Fung, Simon
|
|
|
|
13 |
p. 1411
|
artikel
|
| 34 |
Daclatasvir + Asunaprevir: First Global Approval
|
Poole, Raewyn M.
|
|
2014
|
|
13 |
p. 1559-1571
|
artikel
|
| 35 |
Decitabine/Cedazuridine: First Approval
|
Dhillon, Sohita
|
|
|
|
13 |
p. 1373-1378
|
artikel
|
| 36 |
Delafloxacin: First Global Approval
|
Markham, Anthony
|
|
2017
|
|
13 |
p. 1481-1486
|
artikel
|
| 37 |
Delafloxacin: First Global Approval
|
Markham, Anthony
|
|
2018
|
|
13 |
p. 1481-1486
|
artikel
|
| 38 |
Developing New Drugs for Diabetes and Cardiometabolic Disorders
|
Krentz, Andrew J.
|
|
2012
|
|
13 |
p. 1709-1711
|
artikel
|
| 39 |
Dexmethylphenidate
|
Keating, Gillian M.
|
|
2002
|
|
13 |
p. 1899-1904
|
artikel
|
| 40 |
Dexmethylphenidate
|
Zito, Julie M.
|
|
2002
|
|
13 |
p. 1905-1907
|
artikel
|
| 41 |
Dexmethylphenidate
|
Arnold, L. Eugene
|
|
2002
|
|
13 |
p. 1905
|
artikel
|
| 42 |
Dexmethylphenidate
|
Stein, Mark A.
|
|
2002
|
|
13 |
p. 1905
|
artikel
|
| 43 |
Diabetic Macular Edema: Options for Adjunct Therapy
|
Calvo, Pilar
|
|
2015
|
|
13 |
p. 1461-1469
|
artikel
|
| 44 |
Direct-Acting Antivirals and the Risk of Arrhythmias and Conduction Disorders in Patients with Chronic Hepatitis C: A French Nationwide Cohort Study
|
Lam, Laurent
|
|
|
|
13 |
p. 1207-1213
|
artikel
|
| 45 |
Efmoroctocog Alfa: A Review in Haemophilia A
|
Frampton, James E.
|
|
2016
|
|
13 |
p. 1281-1291
|
artikel
|
| 46 |
Eladocagene Exuparvovec: First Approval
|
Keam, Susan J.
|
|
|
|
13 |
p. 1427-1432
|
artikel
|
| 47 |
Empagliflozin/Linagliptin: A Review in Type 2 Diabetes
|
Kim, Esther S.
|
|
2015
|
|
13 |
p. 1547-1557
|
artikel
|
| 48 |
Entrectinib: First Global Approval
|
Al-Salama, Zaina T.
|
|
2019
|
|
13 |
p. 1477-1483
|
artikel
|
| 49 |
Eplerenone: A Review of Its Use in Patients with Chronic Systolic Heart Failure and Mild Symptoms
|
Dhillon, Sohita
|
|
2013
|
|
13 |
p. 1451-1462
|
artikel
|
| 50 |
Erratum to: Cabazitaxel: a novel microtubule inhibitor
|
Villanueva, C
|
|
2011
|
|
13 |
p. 1720
|
artikel
|
| 51 |
Erratum to: Psychosis in Parkinson’s Disease: Epidemiology, Pathophysiology, and Management
|
Chang, Anna
|
|
2016
|
|
13 |
p. 1319
|
artikel
|
| 52 |
Evolocumab: First Global Approval
|
Markham, Anthony
|
|
2015
|
|
13 |
p. 1567-1573
|
artikel
|
| 53 |
Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine
|
Fox, Annette
|
|
2018
|
|
13 |
p. 1297-1308
|
artikel
|
| 54 |
Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine
|
Fox, Annette
|
|
|
|
13 |
p. 1297-1308
|
artikel
|
| 55 |
Factors Contributing to the Efficacy-Effectiveness Gap in the Case of Orphan Drugs for Metabolic Diseases
|
Schuller, Y.
|
|
2017
|
|
13 |
p. 1461-1472
|
artikel
|
| 56 |
Fenofibrate and Dyslipidemia: Still a Place in Therapy?
|
Tarantino, Nicola
|
|
2018
|
|
13 |
p. 1289-1296
|
artikel
|
| 57 |
Fixed-Dose Combinations as Initial Therapy for Hypertension
|
Waeber, Bernard
|
|
2009
|
|
13 |
p. 1761-1776
|
artikel
|
| 58 |
Fluticasone Furoate/Vilanterol: A Review of Its Use in Chronic Obstructive Pulmonary Disease
|
McKeage, Kate
|
|
2014
|
|
13 |
p. 1509-1522
|
artikel
|
| 59 |
Focus on New Drugs in Development Against Human Cytomegalovirus
|
Emery, Vincent C.
|
|
2002
|
|
13 |
p. 1853-1858
|
artikel
|
| 60 |
Functional Dyspepsia: Diagnostic and Therapeutic Approaches
|
Sayuk, Gregory S.
|
|
|
|
13 |
p. 1319-1336
|
artikel
|
| 61 |
Glycopyrronium/Formoterol: A Review in COPD
|
Al-Salama, Zaina T.
|
|
2019
|
|
13 |
p. 1455-1466
|
artikel
|
| 62 |
Guselkumab: First Global Approval
|
Markham, Anthony
|
|
2017
|
|
13 |
p. 1487-1492
|
artikel
|
| 63 |
Hetrombopag: First Approval
|
Syed, Yahiya Y.
|
|
|
|
13 |
p. 1581-1585
|
artikel
|
| 64 |
HIV-Associated Lipodystrophy: Impact of Antiretroviral Therapy
|
Guaraldi, Giovanni
|
|
2013
|
|
13 |
p. 1431-1450
|
artikel
|
| 65 |
11β-HSD1 Inhibitors for the Treatment of Type 2 Diabetes and Cardiovascular Disease
|
Anderson, Anna
|
|
2013
|
|
13 |
p. 1385-1393
|
artikel
|
| 66 |
Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies
|
Valdivielso, José M.
|
|
|
|
13 |
p. 1467-1489
|
artikel
|
| 67 |
Inhaled Antimicrobials for Ventilator-Associated Pneumonia: Practical Aspects
|
Poulakou, Garyphallia
|
|
2017
|
|
13 |
p. 1399-1412
|
artikel
|
| 68 |
Inhaled Antimicrobials for Ventilator-Associated Pneumonia: Practical Aspects
|
Poulakou, Garyphallia
|
|
|
|
13 |
p. 1399-1412
|
artikel
|
| 69 |
Inhaled Liposomal Antimicrobial Delivery in Lung Infections
|
Bassetti, Matteo
|
|
|
|
13 |
p. 1309-1318
|
artikel
|
| 70 |
Inotersen: First Global Approval
|
Keam, Susan J.
|
|
2018
|
|
13 |
p. 1371-1376
|
artikel
|
| 71 |
Insulin Aspart
|
Chapman, Therese M.
|
|
2002
|
|
13 |
p. 1945-1981
|
artikel
|
| 72 |
Insulin Degludec/Liraglutide: A Review in Type 2 Diabetes
|
Greig, Sarah L.
|
|
2015
|
|
13 |
p. 1523-1534
|
artikel
|
| 73 |
Insulin Tregopil: An Ultra-Fast Oral Recombinant Human Insulin Analog: Preclinical and Clinical Development in Diabetes Mellitus
|
Joshi, Shashank
|
|
|
|
13 |
p. 1161-1178
|
artikel
|
| 74 |
Interactions Between Herbal Medicines and Prescribed Drugs
|
Izzo, Angelo A.
|
|
2009
|
|
13 |
p. 1777-1798
|
artikel
|
| 75 |
Lenalidomide: A Review in Newly Diagnosed Multiple Myeloma as Maintenance Therapy After ASCT
|
Syed, Yahiya Y.
|
|
2017
|
|
13 |
p. 1473-1480
|
artikel
|
| 76 |
Lenalidomide: A Review in Previously Treated Follicular Lymphoma
|
Blair, Hannah A.
|
|
|
|
13 |
p. 1337-1344
|
artikel
|
| 77 |
Leveraging Cancer Therapeutics for the HIV Cure Agenda: Current Status and Future Directions
|
Polizzotto, Mark N.
|
|
2015
|
|
13 |
p. 1447-1459
|
artikel
|
| 78 |
Linagliptin
|
Deeks, Emma D.
|
|
2012
|
|
13 |
p. 1793-1824
|
artikel
|
| 79 |
Lurbinectedin: First Approval
|
Markham, Anthony
|
|
|
|
13 |
p. 1345-1353
|
artikel
|
| 80 |
Macitentan: A Review of Its Use in Patients with Pulmonary Arterial Hypertension
|
Dhillon, Sohita
|
|
2014
|
|
13 |
p. 1495-1507
|
artikel
|
| 81 |
Management of Ascites
|
Rochling, Fedja A.
|
|
2009
|
|
13 |
p. 1739-1760
|
artikel
|
| 82 |
Management of Bacterial Urinary Tract Infections in Adult Patients with Diabetes Mellitus
|
Meiland, Ruby
|
|
2002
|
|
13 |
p. 1859-1868
|
artikel
|
| 83 |
Management of Hyperglycemia in Patients With Acromegaly Treated With Pasireotide LAR
|
Samson, Susan L.
|
|
2016
|
|
13 |
p. 1235-1243
|
artikel
|
| 84 |
Management of Patients with Acute Coronary Syndromes
|
Eikelboom, John W.
|
|
2002
|
|
13 |
p. 1839-1852
|
artikel
|
| 85 |
Micronised Fenofibrate
|
Keating, Gillian M.
|
|
2002
|
|
13 |
p. 1909-1944
|
artikel
|
| 86 |
Molecular and Pharmacologic Properties of the Anticancer Quinolone Derivative Vosaroxin: A New Therapeutic Agent for Acute Myeloid Leukemia
|
Jamieson, Gene C.
|
|
2016
|
|
13 |
p. 1245-1255
|
artikel
|
| 87 |
Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations
|
Veronese, Nicola
|
|
|
|
13 |
p. 1347-1355
|
artikel
|
| 88 |
Natalizumab: A Review of Its Use in the Management of Relapsing-Remitting Multiple Sclerosis
|
McCormack, Paul L.
|
|
|
|
13 |
p. 1463-1481
|
artikel
|
| 89 |
Natalizumab: A Review of Its Use in the Management of Relapsing-Remitting Multiple Sclerosis
|
McCormack, Paul L.
|
|
2013
|
|
13 |
p. 1463-1481
|
artikel
|
| 90 |
Nerve Growth Factor Antagonists: Is the Future of Monoclonal Antibodies Becoming Clearer?
|
Bannwarth, Bernard
|
|
2017
|
|
13 |
p. 1377-1387
|
artikel
|
| 91 |
New Oral Anticoagulants
|
Poulsen, Birgitte Klindt
|
|
2012
|
|
13 |
p. 1739-1753
|
artikel
|
| 92 |
Non-dopaminergic Treatments for Motor Control in Parkinson’s Disease
|
Fox, Susan H.
|
|
2013
|
|
13 |
p. 1405-1415
|
artikel
|
| 93 |
On the Verge of Precision Medicine in Diabetes
|
Li, Josephine H.
|
|
|
|
13 |
p. 1389-1401
|
artikel
|
| 94 |
Opicapone: A Review in Parkinson’s Disease
|
Scott, Lesley J.
|
|
2016
|
|
13 |
p. 1293-1300
|
artikel
|
| 95 |
Peramivir: A Review in Uncomplicated Influenza
|
Scott, Lesley J.
|
|
|
|
13 |
p. 1363-1370
|
artikel
|
| 96 |
Peramivir: A Review in Uncomplicated Influenza
|
Scott, Lesley J.
|
|
2018
|
|
13 |
p. 1363-1370
|
artikel
|
| 97 |
Pertuzumab: A Review of Its Use for First-Line Combination Treatment of HER2-Positive Metastatic Breast Cancer
|
McCormack, Paul L.
|
|
2013
|
|
13 |
p. 1491-1502
|
artikel
|
| 98 |
Pharmaco-Immunomodulatory Therapy in COVID-19
|
Rizk, John G.
|
|
|
|
13 |
p. 1267-1292
|
artikel
|
| 99 |
Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy
|
Franco, Valentina
|
|
2019
|
|
13 |
p. 1435-1454
|
artikel
|
| 100 |
Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review
|
Rooij, Willemijn E. de
|
|
2019
|
|
13 |
p. 1419-1434
|
artikel
|
| 101 |
Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents
|
Johnson, Stephen A.
|
|
|
|
13 |
p. 1367-1388
|
artikel
|
| 102 |
Pharmacotherapy for Focal Seizures in Children and Adolescents
|
Stevens, Clare E.
|
|
2018
|
|
13 |
p. 1321-1337
|
artikel
|
| 103 |
Pharmacotherapy for Status Epilepticus
|
Trinka, Eugen
|
|
2015
|
|
13 |
p. 1499-1521
|
artikel
|
| 104 |
Phosphodiesterase 4 Inhibitor Therapies for Atopic Dermatitis: Progress and Outlook
|
Ahluwalia, Jusleen
|
|
2017
|
|
13 |
p. 1389-1397
|
artikel
|
| 105 |
Pimitespib: First Approval
|
Hoy, Sheridan M.
|
|
|
|
13 |
p. 1413-1418
|
artikel
|
| 106 |
Pitolisant: First Global Approval
|
Syed, Yahiya Y.
|
|
2016
|
|
13 |
p. 1313-1318
|
artikel
|
| 107 |
Polatuzumab Vedotin: First Global Approval
|
Deeks, Emma D.
|
|
2019
|
|
13 |
p. 1467-1475
|
artikel
|
| 108 |
Polatuzumab Vedotin: First Global Approval
|
Deeks, Emma D.
|
|
|
|
13 |
p. 1467-1475
|
artikel
|
| 109 |
Polymorphisms of Estrogen Receptors and Risk of Depression
|
Ryan, Joanne
|
|
2012
|
|
13 |
p. 1725-1738
|
artikel
|
| 110 |
Prevention and Treatment of Bleeding with Direct Oral Anticoagulants
|
Crawley, R. Monroe
|
|
|
|
13 |
p. 1293-1308
|
artikel
|
| 111 |
Prevention of Venous Thromboembolism with New Oral Anticoagulants versus Standard Pharmacological Treatment in Acute Medically Ill Patients
|
Albertsen, Ida Ehlers
|
|
2012
|
|
13 |
p. 1755-1764
|
artikel
|
| 112 |
Pyelonephritis in Pregnancy
|
Jolley, Jennifer A.
|
|
|
|
13 |
p. 1643-1655
|
artikel
|
| 113 |
Rationale for and Review of Neoadjuvant Therapy Prior to Radical Prostatectomy for Patients with High-Risk Prostate Cancer
|
McKay, Rana R.
|
|
2013
|
|
13 |
p. 1417-1430
|
artikel
|
| 114 |
Recent Advances in Antiarrhythmic Drug Therapy
|
Saljic, Arnela
|
|
|
|
13 |
p. 1147-1160
|
artikel
|
| 115 |
Recent Clinical Advances in Pharmacotherapy for Levodopa-Induced Dyskinesia
|
Müller, Thomas
|
|
2019
|
|
13 |
p. 1367-1374
|
artikel
|
| 116 |
Reduced-Antigen, Combined Diphtheria, Tetanus and Acellular Pertussis Vaccine, Adsorbed (Boostrix®)
|
McCormack, Paul L.
|
|
2012
|
|
13 |
p. 1765-1791
|
artikel
|
| 117 |
Remdesivir: A Review in COVID-19
|
Blair, Hannah A.
|
|
|
|
13 |
p. 1215-1237
|
artikel
|
| 118 |
Remdesivir: First Approval
|
Lamb, Yvette N.
|
|
|
|
13 |
p. 1355-1363
|
artikel
|
| 119 |
Rivaroxaban
|
Duggan, Sean T.
|
|
2009
|
|
13 |
p. 1829-1851
|
artikel
|
| 120 |
Rosacea: New and Emerging Treatments
|
Moustafa, Farah A.
|
|
2014
|
|
13 |
p. 1457-1465
|
artikel
|
| 121 |
Salmeterol/Fluticasone Propionate
|
McKeage, Kate
|
|
2009
|
|
13 |
p. 1799-1828
|
artikel
|
| 122 |
Selective Serotonin Reuptake Inhibitors for Premenstrual Dysphoric Disorder
|
Pearlstein, Teri
|
|
2002
|
|
13 |
p. 1869-1885
|
artikel
|
| 123 |
Selinexor: First Global Approval
|
Syed, Yahiya Y.
|
|
2019
|
|
13 |
p. 1485-1494
|
artikel
|
| 124 |
Short- versus Long-Course Antibacterial Therapy for Community-Acquired Pneumonia
|
Dimopoulos, George
|
|
|
|
13 |
p. 1841-1854
|
artikel
|
| 125 |
Socioeconomic Impact of Seasonal (Epidemic) Influenza and the Role of Over-the-Counter Medicines
|
Klepser, Michael E.
|
|
2014
|
|
13 |
p. 1467-1479
|
artikel
|
| 126 |
Sonidegib: First Global Approval
|
Burness, Celeste B.
|
|
2015
|
|
13 |
p. 1559-1566
|
artikel
|
| 127 |
Sotorasib: First Approval
|
Blair, Hannah A.
|
|
|
|
13 |
p. 1573-1579
|
artikel
|
| 128 |
Sovateltide: First Approval
|
Keam, Susan J.
|
|
|
|
13 |
p. 1239-1244
|
artikel
|
| 129 |
Sulbactam/Durlobactam: First Approval
|
Keam, Susan J.
|
|
|
|
13 |
p. 1245-1252
|
artikel
|
| 130 |
Sumatriptan Iontophoretic Transdermal System: A Review of Its Use in Patients with Acute Migraine
|
Garnock-Jones, Karly P.
|
|
2013
|
|
13 |
p. 1483-1490
|
artikel
|
| 131 |
Supervised Injectable Opioid Treatment for the Management of Opioid Dependence
|
Bell, James
|
|
2018
|
|
13 |
p. 1339-1352
|
artikel
|
| 132 |
Suprachoroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema
|
Fung, Simon
|
|
|
|
13 |
p. 1403-1410
|
artikel
|
| 133 |
Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine
|
Strang, John
|
|
2019
|
|
13 |
p. 1395-1418
|
artikel
|
| 134 |
Tavaborole: First Global Approval
|
Markham, Anthony
|
|
2014
|
|
13 |
p. 1555-1558
|
artikel
|
| 135 |
Tecovirimat: First Global Approval
|
Hoy, Sheridan M.
|
|
2018
|
|
13 |
p. 1377-1382
|
artikel
|
| 136 |
Tecovirimat: First Global Approval
|
Hoy, Sheridan M.
|
|
|
|
13 |
p. 1377-1382
|
artikel
|
| 137 |
Tetravalent Dengue Vaccine: A Review in the Prevention of Dengue Disease
|
Scott, Lesley J.
|
|
2016
|
|
13 |
p. 1301-1312
|
artikel
|
| 138 |
The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer
|
Taieb, Julien
|
|
2019
|
|
13 |
p. 1375-1394
|
artikel
|
| 139 |
The Optimal Management of Follicular Lymphoma: An Evolving Field
|
Ujjani, Chaitra
|
|
2013
|
|
13 |
p. 1395-1403
|
artikel
|
| 140 |
The Potential Role of Clinical Metagenomics in Infectious Diseases: Therapeutic Perspectives
|
d’Humières, Camille
|
|
|
|
13 |
p. 1453-1466
|
artikel
|
| 141 |
Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease
|
Matera, Maria Gabriella
|
|
2016
|
|
13 |
p. 1257-1270
|
artikel
|
| 142 |
Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review
|
Veerman, Selene R. T.
|
|
2017
|
|
13 |
p. 1423-1459
|
artikel
|
| 143 |
Upacicalcet: First Approval
|
Hoy, Sheridan M.
|
|
|
|
13 |
p. 1593-1596
|
artikel
|
| 144 |
Use of Integrase Inhibitors in HIV-Infected Children and Adolescents
|
Dehority, Walter
|
|
2015
|
|
13 |
p. 1483-1497
|
artikel
|
| 145 |
Vadadustat: First Approval
|
Markham, Anthony
|
|
|
|
13 |
p. 1365-1371
|
artikel
|
| 146 |
13-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults
|
Plosker, Greg L.
|
|
2015
|
|
13 |
p. 1535-1546
|
artikel
|
| 147 |
Valsartan/Hydrochlorothiazide
|
Wellington, Keri
|
|
2002
|
|
13 |
p. 1983-2005
|
artikel
|
| 148 |
Vutrisiran: First Approval
|
Keam, Susan J.
|
|
|
|
13 |
p. 1419-1425
|
artikel
|
| 149 |
Will Abuse-Deterrent Formulations of Opioid Analgesics Be Successful in Achieving Their Purpose?
|
Bannwarth, Bernard
|
|
2012
|
|
13 |
p. 1713-1723
|
artikel
|
Tijdschrift beschrijving